Vivani Medical
VANI
33 hedge funds and large institutions have $3.93M invested in Vivani Medical in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 12 reducing their positions, and 5 closing their positions.
2% more capital invested
Capital invested by funds: $3.83M → $3.93M (+$92.9K)
0.49% less ownership
Funds ownership: 8.94% → 8.45% (-0.49%)
6% less funds holding
Funds holding: 35 → 33 (-2)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
67% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 12
Top Buyers
Top Sellers
| 1 |
TWM
Tanager Wealth Management
Goring On Thames,
United Kingdom
|
-$272K |
| 2 |
Renaissance Technologies
New York
|
-$48K |
| 3 |
Millennium Management
New York
|
-$25.1K |
| 4 |
Jane Street
New York
|
-$18.8K |
| 5 |
CC
Centiva Capital
New York
|
-$12.3K |
VANI Hedge Fund Activity: Q1 2023 in Review
33 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q1 2023, worth a combined $3.93M — up 2.4% from $3.83M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VANI and 3 opened new positions — a net loss of 2 holders — while 12 trimmed existing stakes and 4 added.
The largest buyer was Vanguard Group, adding an estimated $114K. The largest seller was Tanager Wealth Management, cutting an estimated $272K.
- 33 institutional investors held Vivani Medical (VANI) as of Q1 2023, down from 35 in Q4 2022.
- Funds reported $3.93M of Vivani Medical stock for Q1 2023, up 2.4% quarter-over-quarter.
- 3 funds opened new Vivani Medical positions in Q1 2023 and 5 closed out, a net change of -2 holders.
- The largest Vivani Medical buyer in Q1 2023 was Vanguard Group, an estimated $114K added.
- The largest Vivani Medical seller in Q1 2023 was Tanager Wealth Management, an estimated $272K sold.
Based on aggregated 13F filings for Q1 2023.